Accès gratuit
Numéro |
Med Sci (Paris)
Volume 27, Numéro 3, Mars 2011
|
|
---|---|---|
Page(s) | 297 - 302 | |
Section | M/S revues | |
DOI | https://doi.org/10.1051/medsci/2011273297 | |
Publié en ligne | 30 mars 2011 |
- DominiciM, Le BlancK, MuellerI, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006 ; 8 : 315-317. [CrossRef] [PubMed] [Google Scholar]
- CrisanM, YapS, CasteillaL, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008 ; 3 : 301-313. [CrossRef] [PubMed] [Google Scholar]
- SensebéL, BourinP. Producing MSC according GMP: process and controls. Biomed Mater Eng 2008 ; 18 : 173-177. [PubMed] [Google Scholar]
- BaxterMA, WynnRF, JowittSN, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004 ; 22 : 675-682. [CrossRef] [PubMed] [Google Scholar]
- StolzingA, JonesE, McGonagleD, ScuttA. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008 ; 129 : 163-173. [CrossRef] [PubMed] [Google Scholar]
- KernS, EichlerH, StoeveJ, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006 ; 24 : 1294-1301. [CrossRef] [PubMed] [Google Scholar]
- BiebackK, KernS, KlüterH, EichlerH. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004 ; 22 : 625-634. [CrossRef] [PubMed] [Google Scholar]
- GronthosS, ZannettinoACW, HaySJ, et al. Molecular and cellular characterisation of highly purified stromal cells derived from human bone marrow. Cell Sci 2003 ; 116 : 1827-1835. [Google Scholar]
- QuiriciN, SoligoD, BossolascoP, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002 ; 30 : 783-791. [CrossRef] [PubMed] [Google Scholar]
- DeschaseauxF, CharbordP. Human marrow stromal precursors are alpha 1 integrin subunit-positive. Cell Physiol 2000 ; 184 : 319-325. [CrossRef] [Google Scholar]
- KoçON, GersonSL, CooperBW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultured-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. Clin Oncol 2000 ; 18 : 307-316. [Google Scholar]
- ColterDC, SekiyaI, ProckopDJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 2001 ; 98 : 7841-7845. [CrossRef] [Google Scholar]
- SekiyaI, LarsonBJ, SmithJR, et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002 ; 20 : 530-541. [CrossRef] [PubMed] [Google Scholar]
- BanfiA, MuragliaA, DozinB, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000 ; 28 : 707-715. [CrossRef] [PubMed] [Google Scholar]
- MuragliaA, CanceddaR, QuartoR. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. Cell Sci 2000 ; 113 : 1161-1166. [Google Scholar]
- NgF, BoucherS, KohS, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008 ; 112 : 295-307. [CrossRef] [PubMed] [Google Scholar]
- MüllerI, KordowichS, HolzwarthC, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 2006 ; 8 : 437-444. [CrossRef] [PubMed] [Google Scholar]
- KocaoemerA, KernS, KlüterH, BiebackK. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007 ; 25 : 1270-1278. [CrossRef] [PubMed] [Google Scholar]
- ChaseLG, LakshmipathyU, SolchagaLA, et al. A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther 2010 ; 1 : 8. [CrossRef] [PubMed] [Google Scholar]
- TarteK, GaillardJ, LatailladeJJ, et al. Société française de greffe de moelle et thérapie cellulaire. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010 ; 115 : 1549-1553. [CrossRef] [PubMed] [Google Scholar]
- GodaraP, McFarlandCD, NordonRE. Design of bioreactors for mesenchymal stem cell tissue engineering. Chem Technol Biotechnol 2010 ; 83 : 408-420. [Google Scholar]
- SerakinciN, GuldbergP, BurnsJS, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004 ; 23 : 5095-5098. [CrossRef] [PubMed] [Google Scholar]
- RubioD, Garcia-CastroJ, MartınMC, et al. Spontaneous human adult stem cell transformation. Cancer Res 2005 ; 65 : 3035-3039. [PubMed] [Google Scholar]
- RoslandGV, SvendsenA, TorsvikA, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009 ; 69 : 5331-5339. [CrossRef] [PubMed] [Google Scholar]
- GarciaS, MartinMC, de la FuenteR, et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 2010 ; 316 : 1648-1650. [CrossRef] [PubMed] [Google Scholar]
- TorsvikA, RoslandGV, SvendsenA, et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track. Cancer Res 2010 ; 70 : 6393-6396. [CrossRef] [PubMed] [Google Scholar]
- HayflickL. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1963 ; 37 : 614-636. [Google Scholar]
- CampisiJ, d’Adda di FagagnaF. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007 ; 8 : 729-740. [CrossRef] [PubMed] [Google Scholar]
- CoppéJP, PatilCK, RodierF, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PloS Biol 2008 ; 12 : 2853-2868. [Google Scholar]
- DjouadF, PlenceP, BonyC, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 ; 102 : 3837-3844. [CrossRef] [PubMed] [Google Scholar]
- HoughtonJM, LiH, FanX, et al. Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cell Dev 2010 ; 19 : 1153-1166. [CrossRef] [Google Scholar]
- WagnerW, HornP, CastoldiM, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PloS One 2008 ; 3 : 1-12. [PubMed] [Google Scholar]
- ProckopDJ, BrennerM, FibbeWE, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010 ; 12 : 576-578. [CrossRef] [PubMed] [Google Scholar]
- BischofO, DejeanA, PineauP. Une revue de la sénescence cellulaire : ami ou ennemi de la promotion tumorale ?Med Sci (Paris) 2009 ; 25 : 153-160. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- CharbordP, CasteillaL. La biologie des cellules souches mésenchymateuses d’origine humaine. Med Sci (Paris) 2011 ; 27 : 261-268. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- LazennecG. Les cellules souches mésenchymateuses : armes ou dangers pour le traitement des cancers ?Med Sci (Paris) 2011 ; 27 : 285-288. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- JorgensenC, DeschaseauxF, Planat-BenardV, GabisonE. Les cellules souches mésenchymateuses : actualités thérapeutiques. Med Sci (Paris) 2011 ; 27 : 275-284. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- VinatierC, BordenaveL, GuicheuxJ, AmédéeJ. Les cellules souches en ingénierie des tissus ostéoarticulaires et vasculaires. Med Sci (Paris) 2011 ; 27 : 289-296. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.